CooperVision Surgical
This article was originally published in The Gray Sheet
Executive Summary
Argus Biomedical's AlphaCor artificial cornea will be the premier offering of Cooper's new ophthalmic surgical division. Cleared via 510(k) in 2002, AlphaCor is suitable for approximately 20,000 corneal implant patients each year, Cooper estimates. Through the purchase of Argus assets, announced Feb. 24, Cooper also acquired AlphaSphere soft orbital implants, still under development. Meanwhile, Ciba Vision divested most of its surgical business in early February, with French firm Ioltech, SA picking up the Vivarte refractive lens family along with several other lenses and surgical product lines...